IRCT20190427043389N1招募中未知
The effect of co-administration of pioglitazone to methamphetamine addict patients therapy regimen on the quality of life and the treatment efficacy.
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 50 years（—）
- 性别
- All
入选标准
- •Methamphetamine-dependent patients admitted to beheshti hospital in zanjan included in the study.
- •Methamphetamine-dependent patients referred to the clinic of beheshti training center of zanjan in the study.
- •The age range of patients is between 20 to 50 years.
排除标准
- •chronic medical conditions include diabetes , severe liver disorder & severe heart disorder.
- •pioglitazone contraindications if any.
研究者
相似试验
招募中
不适用
The effect of pioglitazone on reducing opioid and heroin dependence.IRCT20190427043389N2Zanjan University of Medical Sciences100
进行中（未招募）
不适用
Effect of pioglitazone in patienst with Adrenomyeloneuropathy.X-linked adrenoleukodystrophyEUCTR2011-006113-34-ESAURORA PUJOL ONOFRE
进行中（未招募）
不适用
Effect of Pioglitazone compared to a combination therapy with Ramipril and to a Ramipril monotherapy on low grade inflammation and vascular function in patients with increased cardiovascular risk and an activated inflammationA randomized double-blinded phase II studyon-diabetic hypertensive patients with a hsCRP value > 1.0 mg/L < 10.0 mg/L and pretreated with ACE inhibitors for at least 12 weeks are eligible for study participation.MedDRA version: 8.1Level: LLTClassification code 10003601Term: AtherosclerosisEUCTR2006-004028-35-DETakeda Pharma GmbH
已完成
不适用
Effect of pioglitazone in combination with glimepiride therapy on various parameters of insulin resistance including lipoprotein subclass levels in patients with type 2 diabetesJPRN-UMIN000002461Yamashiro Public Hospital50
进行中（未招募）
不适用
Effects of Pioglitazone in Combination with Glimepiride in Comparison to Glimepiride Monotherapy on Metabolic Control in Patients with Type 2 Diabetes mellitusEUCTR2006-002271-41-DETakeda Pharma GmbH